US Patent Issued to MeiraGTx Gene Regulation on Nov. 25 for "Modified rAAV capsid protein for gene therapy" (Dutch, German, American Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,138, issued on Nov. 25, was assigned to MeiraGTx Gene Regulation Ltd. (London).

"Modified rAAV capsid protein for gene therapy" was invented by Jonathan Douglas Finn (Melrose, Mass.), Dirk Grimm (Heidelberg, Germany), Kathleen Borner (Schriesheim, Germany), Niels Broekstra (Nieuwkoop, Netherlands), Susanne Anna Snoek (Heiloo, Netherlands) and Sabine Maria Gertrude Van Der Sanden (Amsterdam).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to recombinant adeno-associated virus (rAAV) virions for gene therapy, wherein the rAAV virions comprise a novel capsid protein. In particular, the invention relates to the use of such virions in...